Study to Investigate the Absorption, Metabolism and Excretion of Talampanel

Study Title
A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel
Teva Identifier
TAL-MB-100
ClinicalTrials.gov Identifier
NCT00868361
Study Status
Terminated
Trial Condition(s)
Healthy
Interventions
Drug: Talampanel (non-radiolabeled), [14C] Talampanel

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Male
Age Range
18 Years to 55 Years
Trial Duration
05/01/2009 - 09/01/2009
Phase
Phase 1

Study Type

Interventional